SG Singapore
Stand No: 12A22

PRESTIGE BIOPHARMA PTE. LTD. specializes in the discovery and development of innovative biologics. The company’s Herceptin Biosimilar, HD201, is currently projected to launch in the 2019 market. With Herceptin Biosimilar (HD201) and Avastin Biosimilar (HD204) at the top, the company has the leading position globally in the biosimilar market.